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Abstract
Background: Studies show that patients make lifestyle changes soon after certain 
solid tumor diagnoses, suggesting that this may be a teachable moment to motivate 
and promote healthy behaviors. There is a paucity of data regarding changes made 
after a diagnosis of a hematologic malignancy.
Methods: A cross- sectional study of 116 patients at a community oncology center 
who completed anonymous questionnaires was performed. Questions addressed life-
style choices made with respect to smoking, alcohol consumption, recreational drug 
use, diet, and exercise habits before and after diagnosis of a hematologic malignancy. 
Support systems utilized, including psychiatry services, were also assessed.
Results: Patients exhibited significant reduction in smoking behavior (Χ2  =  31.0, 
p < 0.001). 82.4% (n = 14) of one pack per day smokers quit between the time peri-
ods, with nearly all smokers showing a reduction after diagnosis. Alcohol use overall 
did not change significantly, however, 10.3% (n = 12) of patients reported quitting 
drinking completely between time periods. Changes in dietary intake and exercise 
were not statistically significant overall. Utilization of external support systems cor-
related with improved diet as well as decrease in total smoking years.
Conclusions: This study demonstrates that patients exhibited significant lifestyle 
changes after being diagnosed with a hematologic malignancy. Clinicians should take 
advantage of this ‘teachable moment’ to educate patients about positive health behav-
ior changes. Advances in cancer therapeutics have led to an increase in cancer survi-
vors, this education is crucial in reducing the risk of developing chronic comorbidities 
as well as secondary malignancies.
K E Y W O R D S
cancer survivorship, diet, hematologic malignancies, Lifestyle changes, smoking
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1 |  INTRODUCTION
With the advent of various effective and feasible treatment op-
tions for hematologic malignancies, survival rates and quality 
of life have improved significantly over the last few decades.1 
Cancer survivors have been shown to be at increased risk of 
developing chronic comorbidities such as diabetes, obesity, 
and cardiovascular disease.2 Metabolic syndrome associated 
diseases, particularly obesity, have been associated with in-
creased risk of developing secondary cancers (solid tumors 
such as breast, colon, renal cell carcinoma, endometrial, ad-
enocarcinoma of the esophagus).2 Lifestyle modifications 
to change detrimental behaviors such as smoking, alcohol 
consumption, unhealthy diets, and sedentary lifestyle among 
individuals who have been diagnosed with cancer may help 
to improve outcomes, or to reduce the incidence of develop-
ing negative health outcomes related to unhealthy lifestyle 
behaviors. For example, healthier choices have the potential 
to improve prognosis, reduce sequelae of cancer treatments, 
lower risk of cancer recurrence, decrease incidence of a 
second cancer, and/or reduce risk for chronic comorbidities 
such as cardiovascular disease, diabetes, hypertension, and 
obesity.2- 4
Some studies show that cancer survivors make health 
behavior changes (e.g., quitting smoking, improving diet 
and exercise) soon after diagnosis or treatment, suggesting 
that a cancer diagnosis may motivate and promote healthy 
behaviors.3- 9 The American Cancer Society (ACS) has pub-
lished guidelines and principles regarding nutrition, physical 
activity, and alcohol consumption. An ACS study of cancer 
survivors has demonstrated that a cancer diagnosis could be 
a “teachable moment” – an opportunity linking a health mes-
sage to a presenting problem, regardless of the receptivity of 
the patient.2
Strong support systems empower patients to cope with the 
stress and anxiety of diagnosis and treatment. Patients who 
demonstrated positive coping behaviors and those who per-
ceived more social support were more likely to exhibit posi-
tive health behavior changes.10 This is evidenced by studies 
reporting an association with higher risk health behaviors 
in cancer survivors who had higher levels of life stressors. 
Better outcomes were noted when patients took an active ap-
proach to coping strategies compared to those who took a 
passive or indifferent stance.11
Much literature on understanding lifestyle changes comes 
from studying female breast cancer survivors.7,8,12,13 Breast 
cancer survivors have identified family, friends, support 
groups, and spirituality as sources of social support, enabling 
them to cope favorably with the negative physical and psy-
chological aspects of breast cancer.8 A cross- sectional study 
of breast cancer survivors also demonstrated a positive asso-
ciation between active coping strategies and improved diet 
and exercise patterns.12
There is, however, little information available regarding 
lifestyle changes that patients make after being diagnosed 
with a hematologic malignancy. The aim of our study was 
to compare lifestyle modifications (with respect to smoking, 
alcohol consumption, recreational drug use, diet, and exer-
cise habits) in patients made before and after diagnosis of a 
hematological malignancy. We also examined support sys-
tems utilized and barriers to change identified by our patient 
population.
2 |  METHODS
The survey instrument was developed based on the literature 
studying lifestyle changes in female breast cancer survivors 
and the authors’ clinical experience caring for patients with 
hematologic malignancies. The questions addressed lifestyle 
choices made with respect to smoking, alcohol consumption, 
recreational drug use, diet, and exercise habits before and after 
diagnosis of a hematologic malignancy. We also inquired 
about patient demographics and support systems utilized, 
including psychiatry/mental health services. Behavioral pat-
terns were collected as number of days per week the patient 
partook in the behavior. We measured fruit days per week as 
the number of days per week the patient consumed at least 
4– 5 servings of fruit; cereal days per week as the number of 
days per week the patient consumed at least six servings of 
whole grain cereals; low- fat days as the number of days per 
week the patient ingested two or fewer servings of fats and 
oils; and exercise days as the number of days per week the 
patient participated in at least 30 minutes of exercise/activity. 
Two open ended questions were also included to understand 
potential reasons underlying the lifestyle choices that were 
made.
We surveyed adult patients with a diagnosis of a hema-
tologic malignancy at a community oncology center. Adult 
patients aged 18 and older with a diagnosis of a hematologic 
malignancy (i.e., leukemia, lymphoma, or myeloma) either 
currently undergoing treatment or having completed treat-
ment were included. To assess any differences between pa-
tients treated for aggressive vs indolent malignancies, further 
categorization was made. Patients with CLL, CML, and HCL 
were grouped as indolent, patients with NHL, HL, and MM 
as intermediate, and those with AML, ALL, T- cell leukemia, 
and DLBCL as aggressive, The survey instrument also re-
quired patients to self- report their current treatment status 
(ongoing, completed, or never requiring treatment). Patients 
with multiple malignancies, incomplete surveys, and pro-
tected populations (such as pregnant or incarcerated patients) 
were excluded.
Clinic staff provided survey forms to all patients who 
were willing to participate in the study. Completed surveys 
were returned by the patients in sealed envelopes which were 
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immediately placed in a locked container to maintain ano-
nymity. No protected health information was collected on the 
surveys. Members of the research team reviewed and com-
piled data from the anonymous surveys.
2.1 | Statistical methods
Data analyses were conducted for main effects of interest and 
for subgroup analyses where appropriate. For comparisons of 
continuous outcomes, data were first examined for normal-
ity using both the Shapiro- Wilk test and by examination of 
measures of skewness and kurtosis. In this study, the data 
met appropriate distributional assumptions, and therefore a 
paired- samples t- test was used. Changes in categorical re-
sponses were analyzed using the McNemar- Bowker test with 
exact p- values. All analyses were conducted using SPSS (v. 
24).
This study was approved by the Institutional Review 
Board of the University of Nevada School of Medicine, Las 
Vegas (UNLV).
3 |  RESULTS
Of the 139 patients who were approached, nine patients de-
clined to participate in the study, 14 patients were excluded 
due to incomplete surveys (n = 6) and a history of multiple 
malignancies (n = 8), resulting in 116 completed surveys in-
cluded for data analysis. Patient characteristics are described 
in detail in Table 1.
Patients ranged in age from 19 to 89 years, with a median 
age of 62 years (Mean = 60.3, SD = 15.51). Most patients 
were Caucasian (62.1%, n = 72), married or with a partner 
(59.5%, n  =  69), and had a college or vocational degree 
(63.8%, n = 74). Patients were relatively uniformly distrib-
uted in terms of employment status and income. Most pa-
tients had a diagnosis of lymphoma (52.6%, n = 61) and were 
within 2– 10 years since diagnosis (58.6%, n = 68). Regarding 
prognosis, most patients were of intermediate cancer severity 
(60.3%) with either a complete (44.0%) or current (45.7%) 
treatment status (Table 1).
3.1 | Smoking, drug, and alcohol 
use behavior
Smoking behaviors, as measured by packs per day, 
changed significantly after a cancer diagnosis (Χ2 = 31.0, 
p  <  0.001). Most notably, zero nonsmokers initiated 
smoking behavior after diagnosis, a large percentage 
of smokers quit entirely (82.4%, n  =  14, of 1– 2 pack 
per day smokers and 50%, n  −  2, of >2 pack per day 
smokers), with nearly all participants who smoked at time 
one (T1, before diagnosis) reducing their packs per day 
smoked at time two (T2, after diagnosis). This reduction 






Sex Female 56 48.3
Male 60 51.5






Marital status Divorced 19 16.4
Married 66 56.9





Employment Employed 44 37.9
Not employed 35 30.2
Retired 36 31.0
Unknown 1 0.9
Education Less than HS 13 11.2




Income <30 K 29 25
30– 50 K 23 19.8
50– 100 K 25 21.6
>100 K 14 12.1
Unknown 25 21.6
Diagnosis Leukemia 30 25.9
Lymphoma 61 52.6
Myeloma 25 21.6
Years 0– 1 23 19.8
Since 2– 10 68 58.6
Diagnosis >10 25 21.6
Prognosis Aggressive 18 15.5
Indolent 25 21.5
Intermediate 70 60.3
Not reported 3 2.6
Treatment status Complete 51 44.0
Current 53 45.7
Never required 12 10.3
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in smoking also resulted in a significant drop in the total 
number of reported smoking years for patients between 
T1 (mean = 20.77, SE = 2.494) and T2 (mean = 16.71, 
SE  =  2.652) resulting in a mean reduction of 4.1  years 
(t = 2.436, p = 0.023). Alcohol use, measured as drinks 
per week, did not change significantly (Χ2  =  10.6, 
p  =  0.102); however, it is notable that 10.3% (n  =  12) 
of patients reported quitting drinking completely between 
time periods (Table 2). Results in drug and alcohol use as 
reported above were similar between sexes.
Data were too sparse to test significant differences based 
on cancer severity and treatment status, but some results 
were interesting. One patient with aggressive cancer re-
ported smoking >2 packs/day and continued to do so after 
treatment, but nearly all of the other smokers reported de-
creases in packs per day at T2. Further, four patients went 
from multiple drinks per week to 0 reported drinks per week 
between time periods, and this occurred regardless of can-
cer severity. THC use mirrored that of the entire sample. 
Patterns were similar across variables for treatment status, 
with general decreases between time periods. Interestingly, 
even those who never received treatment reported smoking 
cessation.
3.2 | Diet and exercise
Changes in dietary intake and exercise were not consistent 
between time periods. Mean fruit days per week increased 
significantly between time periods (t = 3.100, p = 0.002). 
This result was most notable for males (t = 3.845, p < 0.001), 
those who reported being employed (t = 3.947, p < 0.001), 
those 2– 10  years post diagnosis (t  =  3.204, p  =  0.002), 
those with curable cancers (t  =  2.332, p  =  0.025), and 
those with lymphoma (t  =  3.487, p  =  0.001). This trend 
was also true for those with intermediate cancers and those 
who completed treatment, however was not statistically 
significant.
T A B L E  2  Summary table of changes in drug and alcohol use between Time 1 (before diagnosis) and Time 2 (after diagnosis); percentages are 
shown based on row totals (N)




Change in behavior, cigarette packs per day at Time 2 for the 
same patients compared to Time 1
Χ2 statistic p- value0 <1 1– 2 >2
Smoking (cigarettes)
0 71 71 (100%) 0 (0%) 0 (0%) 0 (0%) 31.0 <0.001
<1 21 14 (66.7%) 6 (28.6%) 1 (4.8%) 0 (0%)
1– 2 17 14 (82.4%) 1 (5.9%) 2 (11.8%) 0 (0%)





Change in behavior, marijuana hits per day at Time 2 for the 
same patients compared to Time 1
Χ2 statistic p- value0 1– 5 5– 10 >10
Marijuana use
0 109 109 (100%) 0 (0%) 0 (0%) 0 (0%) 103.1 <0.001
1– 5 1 0 (0%) 1 (100%) 0 (0%) 0 (0%)
5– 10 2 0 (0%) 0 (0%) 2 (100%) 0 (0%)






Change in behavior, alcoholic drinks per day at Time 2 for the same 
patients compared to Time 1
Χ2 statistic p- value0 <1 1– 5 5– 7 >7
Alcohol consumption
0 61 58 (95.1%) 0 (0%) 3 (4.9%) 0 (0%) 0 (0%) 10.6 0.102
<1 1 0 (0%) 1 (100%) 0 (0%) 0 (0%) 0 (0%)
1– 5 35 7 (20%) 0 (0%) 28 (80%) 0 (0%) 0 (0%)
5– 7 10 1 (10%) 0 (0%) 1 (10%) 8 (80%) 0 (0%)
>7 9 4 (44.4%) 0 (0%) 2 (22.2%) 1 (11.1%) 2 (22.2%)
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Mean cereal days increased slightly, but not significantly, 
from T1 to T2, whereas low fat diet consumption and exer-
cise days slightly decreased from T1 to T2. Fat consumption 
also decreased significantly for those with indolent cancers 
(t  =  2.500, p  =  0.019), and those under current treatment 
(t = 2.599, p = 0.012) (Table 3).
T A B L E  3  Means and standard errors for Time 1 (before diagnosis) and Time 2 (after diagnosis) measurements for Diet and Exercise variables. 
Paired t- tests with exact p- values are reported
Measure Time 1 Time 2 Mean difference t- statistic p- value
Total sample
Fruit days 3.59 (2.090) 4.15 (2.040) −0.557 −3.100 0.002
Cereal days 3.68 (2.286) 3.80 (2.154) −0.114 −0.625 0.534
Fat days 3.46 (2.116) 3.25 (2.151) 0.209 1.468 0.145
Exercise days 3.00 (2.485) 2.92 (2.658) 0.079 0.361 0.719
Cumulative 13.43 (6.446) 14.14 (6.682) −0.704 −1.260 0.210
Aggressive cancer
Fruit days 3.56 (1.977) 4.44 (2.036) −0.889 −1.978 0.064
Cereal days 4.22 (1.896) 4.56 (1.977) −0.333 −0.669 0.513
Fat days 3.00 (1.910) 3.17 (2.229) −0.167 −0.402 0.692
Exercise days 2.76 (2.658) 2.41 (2.763) 0.353 0.636 0.534
Cumulative 13.39 (7.163) 14.44 (7.602) −1.056 −0.629 0.538
Indolent cancer
Fruit days 3.71 (2.258) 3.68 (2.074) 0.036 0.099 0.922
Cereal days 3.59 (2.454) 3.67 (2.386) −0.074 −0.189 0.852
Fat days 3.56 (2.172) 3.00 (2.166) 0.566 2.500 0.019
Exercise days 3.37 (2.388) 2.74 (2.379) 0.630 1.885 0.071
Cumulative 13.32 (6.549) 12.75 (6.287) 0.571 0.676 0.505
Intermediate cancer
Fruit days 3.55 (2.076) 4.26 (2.027) −0.710 −3.088 0.003
Cereal days 3.58 (2.323) 3.65 (2.092) −0.072 −0.317 0.752
Fat days 3.54 (2.158) 3.37 (2.148) 0.171 0.909 0.367
Exercise days 2.91 (2.501) 3.11 (2.748) −0.200 −0.663 0.509
Cumulative 13.49 (6.307) 14.62 (6.607) −1.130 −1.509 0.136
Treatment complete
Fruit days 3.38 (1.905) 4.10 (2.023) −0.720 −2.599 0.012
Cereal days 3.50 (2.197) 3.66 (2.182) −0.160 −0.610 0.545
Fat days 3.57 (2.229) 3.69 (2.214) −0.118 −0.465 0.644
Exercise days 3.16 (2.502) 3.52 (2.735) −0.360 −0.994 0.325
Cumulative 13.42 (6.834) 15.00 (7.332) −1.580 −1.608 0.114
Treatment current
Fruit days 3.75 (2.227) 4.19 (2.039) −0.434 −1.512 0.137
Cereal days 3.88 (2.315) 3.85 (2.052) 0.038 0.133 0.895
Fat days 3.33 (2.007) 2.88 (2.006) 0.442 2.599 0.012
Exercise days 2.77 (2.414) 2.23 (2.438) 0.538 1.678 0.099
Cumulative 13.49 (6.197) 13.19 (6.070) 0.302 0.404 0.688
Treatment never received
Fruit days 3.75 (2.301) 4.17 (2.290) −0.417 −2.159 0.054
Cereal days 3.58 (2.644) 4.17 (2.588) −0.583 −1.134 0.281
Fat days 3.58 (2.234) 3.00 (2.335) 0.583 1.735 0.111
Exercise days 3.33 (2.839) 3.42 (2.746) −0.083 −1.000 0.339
Cumulative 13.25 (6.398) 14.75 (6.398) −1.500 −1.807 0.098
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3.3 | Psychiatric visits and external 
support systems
Interestingly, only 19 patients (16.5%) reported seeing a 
psychiatrist. Two of these patients reported seeking psychi-
atric support at T2 even though they did not have a history 
of seeing a psychiatrist at T1. Of the 17 patients who sought 
psychiatric treatment at T1, eight (47.1%) stopped seeing the 
psychiatrist at T2, though this was not significant (exact bi-
nomial, p = 0.109).
Of further interest is that 50% of those with aggressive can-
cers reported using four or more support systems compared to 
only 25% for indolent and 16% for intermediate cancers; also a 
third of those who completed treatment also used four or more 
support systems, compared to 17% and 8% for those currently 
in treatment and those never receiving treatment, respectively. 
The use of psychiatric treatment did not differ as a function of 
cancer severity or treatment status (all p > 0.05).
Two open- dialog questions were included in our survey 
addressing issues patients faced that were either beneficial or 
detrimental to healthy living. These questions were included in 
order to identify concepts that require further research. These 
descriptive data were reviewed to identify common themes 
expressed by patients. Many patients expressed a heightened 
awareness of health after their cancer diagnosis. Patients fre-
quently identified challenges such as advancing age, comor-
bidities (most common were diabetes, chronic pain, chronic 
kidney disease), lack of familial support, fatigue, reduced ap-
petite, anxiety, stress, and financial burden of healthy choices 
(e.g., “healthy food is expensive, fast- food is cheaper and 
more accessible”) as factors that prevented healthy lifestyle 
changes. Recurring elements supporting positive change in-
cluded maintaining a positive attitude, access to educational 
material/physician counseling, personally researching health-
ful choices, having long- term goals, mindfulness, and strong 
support from family, friends, and/or religion.
4 |  DISCUSSION
Our study demonstrates patients with hematologic malig-
nancies make positive lifestyle and behavior changes, most 
notably by reducing or quitting smoking. Our findings are 
comparable to other studies that have shown similar behav-
ioral change patterns after receiving major diagnoses such as 
cardiovascular disease or solid malignancies.14,15
There is a critical need to improve prevention and man-
agement of chronic comorbidities in the growing population 
of cancer survivors. At the time of a serious diagnosis, pa-
tients experience an increased emotional state, during which 
they often realize or better understand the impact of their 
daily choices. It is in this period that patients are often more 
open to a positive healthcare message and are more likely to 
implement major lifestyle changes. It is important that pro-
viders are aware of this opportunity and utilize it to motivate 
patients to adopt or improve healthy behavior and lifestyle 
choices.2,15 Understanding the rationale behind positive and 
negative changes made by these patients is of great impor-
tance as this will enable healthcare staff to identify factors 
that facilitate or impede positive change. A collaborative 
model integrating technology to deliver behavioral interven-
tions along with routine survivorship services has been sug-
gested to manage healthcare promotion and care coordination 
between the primary care provider and specialist.16
Our patients identified common themes such as current 
health status, treatment side effects, social support, finances, 
motivation, and access to education/research materials as 
among factors influencing health behavior change. Similar 
attitudes and challenges have been identified in other patient 
populations including endometrial cancer survivors17 and 
adolescent/young adult cancer survivors.18 Breast cancer pa-
tients who felt that they had control over their health tended 
to improve diet and exercise habits.13
Diagnostic interviews and self- report instruments have 
revealed high prevalence of depression and psychosocial 
distress in cancer patients.19 The SMaRT Oncology- 2 trial 
showed that a collaborative treatment approach for major 
depression in cancer patients with the assistance of psychia-
trists, primary care physicians, and nurses resulted in reduced 
depression, anxiety, fatigue, pain, improved quality of life, 
overall functioning, and health.20 We observed that only a 
small number of patients in our study utilized the assistance of 
mental health services. Improving screening for depression at 
clinic visits and counseling patients regarding the availability 
and benefit of these services may help to alleviate an unmet 
need. In addition to psychiatric visits, external support sys-
tems may be important for lifestyle changes in these patients. 
Patients who perceived having more social support were bet-
ter able to cope with the stresses of a cancer diagnosis and 
treatment, and were more likely to make positive health be-
havior changes.10 Though sample sizes are often small when 
doing subanalyses, our study suggests that having external 
support systems is related to decreased total smoking years 
(1– 3 support systems mean difference  =  3.816, t  =  2.199, 
p = 0.041) and increased fruit days per week (1– 3 support 
systems mean difference = −0.537, t = −2.507, p = 0.014; 
4+ support systems mean difference = −0.963, t = −2.871, 
p = 0.008).
We recognize there are some limitations to this study. 
Some degree of recall bias is anticipated; patients may 
overestimate the extent of lifestyle modifications made, 
and may not be entirely truthful about the magnitude of 
changes implemented. Our sample size was not large 
enough to perform detailed subgroup analyses. We also did 
not assess the true impact of the teachable moment on our 
patients as we did not survey how they were counseled on 
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behavioral modifications at the time of diagnosis. It is also 
possible that some long- term survivors may have made 
short- lived changes initially that were not sustained and 
therefore not captured.
Future directions: The initial results of this study serve 
to generate hypotheses for future research and to underscore 
the importance of assessing lifestyle behaviors as a critical 
component of holistic cancer treatment. Providing patients 
with adequate advice and strong support regarding lifestyle 
modification, taking advantage of the “teachable moment”, 
along with close follow- up at regular intervals to ensure that 
the positive behaviors are sustained, is of utmost importance. 
This multidimensional support will ultimately improve the 
well- being and quality of life of patients with hematologic ma-
lignancies and decrease the burden of chronic comorbidities.
5 |  CONCLUSION
This study demonstrates that patients exhibit mostly positive 
behavioral changes after diagnosis of a hematologic malig-
nancy. A large percentage of these patients quit smoking com-
pletely, and nearly all smokers reduced the amount smoked. 
Overall, our patients displayed improvements in diet, but not 
exercise. There was also a trend towards positive behavioral 
changes in patients with more aggressive malignancies. We 
observed that only a small number of patients in our study 
utilized the assistance of mental health services, outlining that 
this is a clear unmet need. Having external support systems 
appeared to be related to positive behavior changes.
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